DuChemBIO Co.,Ltd.

DuChemBIO Co.,Ltd. develops, produces, and sells radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for Parkinson's disease and Parkinson's syndrome, F-DOPA for brain tumor diagnosis, Neuraceq and Vizamyl for Alzheimer's disease, FES for metastatic breast cancer, FACBC for prostate cancer, FDG for tumors, and NaF for bone-related diseases. The company was founded in 2002 and is based in Seoul, South Korea.